NRC
$17.73
National Research Corporation provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States.
Intraday
Recent News
What Makes National Research Corporation (NRC) a Good Investment Choice?
Long Cast Advisers, an investment management firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. In Q4 2025, the Portfolio’s cumulative net return increased by 1%, but the cumulative portfolio for the year remained flat. Since its inception in November 2015, the portfolio has delivered a cumulative return […]
NRC's Q4 Earnings Down Y/Y on High Client Attrition, Stock Falls 27%
NRC Health's Q4 EPS and revenues decline year amid prior client attrition, though recurring contract value grew 8%, pointing to recovery prospects in 2026.
A Look At The Fair Value Of National Research Corporation (NASDAQ:NRC)
Key Insights National Research's estimated fair value is US$15.13 based on 2 Stage Free Cash Flow to Equity Current...
National Research Q4 Earnings Call Highlights
National Research (NASDAQ:NRC) executives pointed to improving sales momentum and recurring contract value growth during the company’s fourth-quarter earnings call, while acknowledging year-over-year revenue pressure tied to elevated attrition experienced in 2024. Fourth-quarter results For the fou
National Research Says Pairing NPS With HCAHPS Can Boost Patient Experience—and Reimbursement
National Research (NASDAQ:NRC) leaders Sarah Fryda and Jason Messerli told webcast attendees that hospitals can use Net Promoter Score (NPS) and other real-time patient feedback tools to strengthen performance on the Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS) survey, a